Effectiveness of Major Ozone Autohemotherapy in the Treatment of Fibromyalgia Syndrome

Emine Dundar Ahi, MD

Status: Completed

Conditions: Fibromyalgia Syndrome

Treatments: Other: major ozone autohemotherapy

Study type: Observational

Funder types: Other

Identifiers

NCT05034770

2020-161

Details and patient eligibility

About

Patients who were admitted to the Physical Medicine and Rehabilitation (PMR) outpatient clinic of our hospital between January 2017 and December 2020 and were treated with Major ozone autohemotherapy with a diagnosis of Fibromyalgia syndrome will include to the study. Visual anolog scale (VAS), Fibromyalgia Impact Questionnare (FIQ) and Short Form Health Survey-36 (SF-36) scores of the patients before and after treatment were recorded. Statistical analysis of these outcome scores will be made.

Enrollment: 45 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Exclusion Criteria:

• has pregnancy,
• has primary romatological disease,
• has primary psychiatric disease
• <18, >60 years old patients